BFAM Stock Today, February 13: Q4, FY2025 Results; FY26 Growth Guide

Bright Horizons earnings are in focus after Q4 and full-year 2025, with management outlining an FY26 growth path. Shares of BFAM trade in USD, but UK investors watch the guide for demand and margin signals. The stock sits well below its 50 and 200‑day averages, so today’s moves may hinge on confidence in enrolment, employer budgets, and cost control. We break down the update, valuation, technicals, and the key checks for a GB portfolio.

Q4 and FY2025 snapshot

Bright Horizons earnings centre on three engines: full‑service child care, back‑up care, and education advisory. Post‑pandemic utilisation and employer-funded back‑up care remain the swing factors. The company operates in the US and UK, so cross‑market demand matters for growth quality. For headline context and event timing, see this preview from Investing.com source.

TTM EPS is 3.47 with a net margin near 7.0%. Operating cash flow per share is 5.66 and free cash flow per share is 4.07. On valuation, the stock trades around 23x TTM earnings, EV to EBITDA near 15.4, and EV to Sales about 2.18. Net debt to EBITDA is roughly 4.0 with interest coverage of 7.1x, so balance sheet flexibility is moderate.

Bright Horizons stock shows a 1‑year change of about -30.9% and YTD of about -17.7%. The 52‑week range is 77.25 to 132.99. The price sits below the 50‑day average of 97.46 and the 200‑day of 109.89, highlighting sentiment reset before guidance. With a price to sales near 1.61 and price to book about 3.27, execution on FY26 targets is key.

FY26 guidance and today’s drivers

Management projected FY26 revenue growth, which investors can cross‑check here source. We look for colour on enrolment, centre utilisation, and employer contract renewals. For Bright Horizons earnings, a credible path that balances centre openings with occupancy and pricing will matter more than top‑line ambition, especially given cost inflation and staffing dynamics.

Fixed‑cost leverage from higher occupancy should support margins, but wages and training remain watch items. TTM operating margin is about 11%. Debt to equity stands near 1.22 with interest coverage at 7.1x, so disciplined capex and steady free cash flow help. Clear targets for labour efficiency, centre productivity, and admin costs can firm confidence in FY26 profitability.

Today’s reaction likely turns on the spread between guidance and investor expectations. A beat‑and‑raise tone could spark relief buying; cautious language on utilisation or employer budgets may cap rallies. UK operations add FX sensitivity for reported results. For Bright Horizons earnings, updates on pipeline visibility, churn, and back‑up care volumes are the quickest tells.

Valuation, sentiment, and technical setup

At roughly 23x TTM earnings and EV to EBITDA near 15.4, valuation assumes stable mid‑cycle margins. The Street skew is mixed: 1 Buy, 3 Hold, 1 Sell, with a Hold‑leaning consensus. Our stock grade is B with a HOLD suggestion, reflecting decent growth and quality against leverage and utilisation risk. Bright Horizons earnings credibility will drive any rerate.

RSI at 52.45 is neutral while ADX at 9.82 signals no clear trend. MACD histogram is slightly positive. Price sits well below the Bollinger lower band at 98.80, showing stretched downside. Watch support near 77.25 and resistance around 83.09. ATR of 2.56 flags elevated daily swings; risk sizing should reflect this.

What GB investors should consider

BFAM is US‑listed and trades in USD, so sterling returns depend on FX. Most UK brokers offer access; complete a W‑8BEN for US withholding on dividends, though BFAM does not pay one today. Compare broker FX fees and spreads. Set alerts around key dates and consider staging entries when volatility is high.

The company operates centres in the UK, alongside its US base, so local employer budgets and hiring plans can influence utilisation. Monitor updates on centre openings, waitlists, and back‑up care demand from large UK clients. For Bright Horizons earnings, steady UK occupancy and pricing would help de‑risk the FY26 revenue guide.

This is a services‑driven consumer cyclical with defensive features from employer partnerships. Position size for execution risk, leverage, and wage inflation. Use stop ranges informed by ATR and support levels. Revisit the thesis if utilisation or contract renewal rates slip. Bright Horizons earnings should anchor any decision to add or trim.

Final Thoughts

Bright Horizons earnings put attention on the FY26 growth guide, centre utilisation, and wage discipline. Valuation sits around 23x TTM earnings with mixed analyst views, so a cleaner path to margin expansion could unlock upside. Technically, the stock trades below key moving averages and prior support, which argues for patience and staged entries. For UK investors, consider USD exposure, broker FX costs, and the company’s UK footprint when sizing a position. Practical next steps: review management’s enrolment and cost targets, set alerts for utilisation and back‑up care KPIs, and track leverage against free cash flow. A consistent FY26 execution story matters more than a one‑quarter print.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.